Detalhe da pesquisa
1.
Safety and Immunogenicity of Respiratory Syncytial Virus Pre-fusion Maternal Vaccine Co-administered with Diphtheria-Tetanus-Pertussis Vaccine: A Phase 2 Study.
J Infect Dis
; 2023 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38133639
2.
Seroprevalence of Bordetella pertussis Infection in Patients With Chronic Obstructive Pulmonary Disease in England: Analysis of the AERIS Cohort.
COPD
; 18(3): 341-348, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33955798
3.
Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older.
J Infect Dis
; 217(11): 1750-1760, 2018 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29529222
4.
Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older.
J Infect Dis
; 216(11): 1352-1361, 2017 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29029224
5.
Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized controlled phase IV study in healthy infants and toddlers using a 2+1 schedule.
Hum Vaccin Immunother
; 20(1): 2342630, 2024 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38687024
6.
Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases.
Hum Vaccin Immunother
; 19(1): 2159731, 2023 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36746754
7.
Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study.
Hum Vaccin Immunother
; 17(3): 723-730, 2021 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32845735
8.
Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis.
Lancet Infect Dis
; 19(9): 988-1000, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31399377
9.
Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials.
Hum Vaccin Immunother
; 15(12): 2865-2872, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31216205